Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Feb 20;188(4):1084-1099.e27.
doi: 10.1016/j.cell.2024.12.007. Epub 2025 Feb 4.

Rhodoquinone carries electrons in the mammalian electron transport chain

Affiliations

Rhodoquinone carries electrons in the mammalian electron transport chain

Jonathan Valeros et al. Cell. .

Abstract

Ubiquinone (UQ), the only known electron carrier in the mammalian electron transport chain (ETC), preferentially delivers electrons to the terminal electron acceptor oxygen (O2). In hypoxia, ubiquinol (UQH2) diverts these electrons onto fumarate instead. Here, we identify rhodoquinone (RQ), an electron carrier detected in mitochondria purified from certain mouse and human tissues that preferentially delivers electrons to fumarate through the reversal of succinate dehydrogenase, independent of environmental O2 levels. The RQ/fumarate ETC is strictly present in vivo and is undetectable in cultured mammalian cells. Using genetic and pharmacologic tools that reprogram the ETC from the UQ/O2 to the RQ/fumarate pathway, we establish that these distinct ETCs support unique programs of mitochondrial function and that RQ confers protection upon hypoxia exposure in vitro and in vivo. Thus, in discovering the presence of RQ in mammals, we unveil a tractable therapeutic strategy that exploits flexibility in the ETC to ameliorate hypoxia-related conditions.

Keywords: electron transport chain; hypoxia; ischemia; metabolism; mitochondria; rhodoquinone.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests J.B.S. and D.M.S. are co-inventors on a patent filed by the Whitehead Institute and UMass Chan Medical School on the uses of rhodoquinone for the treatment of disease. J.B.S. and H.K. are co-inventors on the patent application filed by the UMass Chan Medical School and Princeton University on the composition and usages of compounds for rhodoquinone-ETC-related diseases. H.K. is a co-founder, director, stockholder, and consultant for Crescenta Biosciences Inc. and Farber Partners LLC; a co-founder and shareholder of Chiromics LLC; and a shareholder and scientific advisor to Colorado Research Partners LLC and Integrated Biosciences Inc.

References

    1. Spinelli JB, and Haigis MC (2018). The multifaceted contributions of mitochondria to cellular metabolism. Nat Cell Biol 20, 745–754. 10.1038/s41556-018-0124-1. - DOI - PMC - PubMed
    1. Martinez-Reyes I, and Chandel NS (2020). Mitochondrial TCA cycle metabolites control physiology and disease. Nat Commun 11, 102. 10.1038/s41467-019-13668-3. - DOI - PMC - PubMed
    1. Osellame LD, Blacker TS, and Duchen MR (2012). Cellular and molecular mechanisms of mitochondrial function. Best Pract Res Clin Endocrinol Metab 26, 711–723. 10.1016/j.beem.2012.05.003. - DOI - PMC - PubMed
    1. Spinelli JB, Rosen PC, Sprenger HG, Puszynska AM, Mann JL, Roessler JM, Cangelosi AL, Henne A, Condon KJ, Zhang T, et al. (2021). Fumarate is a terminal electron acceptor in the mammalian electron transport chain. Science 374, 1227–1237. 10.1126/science.abi7495. - DOI - PMC - PubMed
    1. Monzel AS, Enriquez JA, and Picard M (2023). Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab 5, 546–562. 10.1038/s42255-023-00783-1. - DOI - PMC - PubMed

LinkOut - more resources